18 research outputs found
Nerve and vascular biomarkers in skin biopsies differentiate painful from painless peripheral neuropathy in type 2 diabetes
Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and painless-DPN and used to differentiate painful-DPN from painless-DPN. Skin biopsies were collected from 61 patients with type 2 diabetes (T2D), and 19 healthy volunteers (HV). All subjects underwent detailed clinical and neurophysiological assessments. Based on the neuropathy composite score of the lower limbs [NIS(LL)] plus seven tests, the T2D subjects were subsequently divided into three groups: painful-DPN (n = 23), painless-DPN (n = 19), and No-DPN (n = 19). All subjects underwent punch skin biopsy, and immunohistochemistry used to quantify total intraepidermal nerve fibers (IENF) with protein gene product 9.5 (PGP9.5), regenerating nerve fibers with growth-associated protein 43 (GAP43), peptidergic nerve fibers with calcitonin gene-related peptide (CGRP), and blood vessels with von Willebrand Factor (vWF). The results showed that IENF density was severely decreased (p < 0.001) in both DPN groups, with no differences for PGP9.5, GAP43, CGRP, or GAP43/PGP9.5 ratios. There was a significant increase in blood vessel (vWF) density in painless-DPN and No-DPN groups compared to the HV group, but this was markedly greater in the painful-DPN group, and significantly higher than in the painless-DPN group (p < 0.0001). The ratio of sub-epidermal nerve fiber (SENF) density of CGRP:vWF showed a significant decrease in painful-DPN vs. painless-DPN (p = 0.014). In patients with T2D with advanced DPN, increased dermal vasculature and its ratio to nociceptors may differentiate painful-DPN from painless-DPN. We hypothesized that hypoxia-induced increase of blood vessels, which secrete algogenic substances including nerve growth factor (NGF), may expose their associated nociceptor fibers to a relative excess of algogens, thus leading to painful-DPN
Painful and Painless Diabetic Neuropathies: What Is the Difference?
Purpose of Review: The prevalence of diabetes mellitus and its chronic complications are increasing to epidemic proportions. This will unfortunately result in massive increases in diabetic distal symmetrical polyneuropathy (DPN) and its troublesome sequelae, including disabling neuropathic pain (painful-DPN), which affects around 25% of patients with diabetes. Why these patients develop neuropathic pain, while others with a similar degree of neuropathy do not, is not clearly understood. This review will look at recent advances that may shed some light on the differences between painful and painless-DPN. RECENT FINDINGS: Gender, clinical pain phenotyping, serum biomarkers, brain imaging, genetics, and skin biopsy findings have been reported to differentiate painful- from painless-DPN. Painful-DPN seems to be associated with female gender and small fiber dysfunction. Moreover, recent brain imaging studies have found neuropathic pain signatures within the central nervous system; however, whether this is the cause or effect of the pain is yet to be determined. Further research is urgently required to develop our understanding of the pathogenesis of pain in DPN in order to develop new and effective mechanistic treatments for painful-DPN
Whole-genome sequencing reveals host factors underlying critical COVID-19
Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization2,3,4 after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genesâincluding reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)âin critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease
Agricultural Research Management and the Ex Ante Evaluation of Research Proposals : A Review
A review of the ex ante evaluation of research proposals is structured in the wider context of research management. Five functions of research management are identified; initiation, evaluation, selection, implementation and control, and dissemination. After considering the relative weights given to these functions In the. literature, it is concluded that the past emphasis on selection should, for agricultural research, give way to more on evaluation. A review of the literature indicates that ex ante evaluation of research is feasible, whether using simple expected value or more costly and complex probabilistic models. The cost of evaluation should be balanced against investment in both the other research functions and the proposals themselves
Agricultural Research Management and the Ex Ante Evaluation of Research Proposals : A Review
A review of the ex ante evaluation of research proposals is structured in the wider context of research management. Five functions of research management are identified; initiation, evaluation, selection, implementation and control, and dissemination. After considering the relative weights given to these functions In the. literature, it is concluded that the past emphasis on selection should, for agricultural research, give way to more on evaluation. A review of the literature indicates that ex ante evaluation of research is feasible, whether using simple expected value or more costly and complex probabilistic models. The cost of evaluation should be balanced against investment in both the other research functions and the proposals themselves.Research Methods/ Statistical Methods,
OPTIMAL FEEDING POLICIES FOR BROILER PRODUCTION: AN APPLICATION OF DYNAMIC PROGRAMMING
The determination of an optimal feeding and selling strategy for broiler production given a space constraint is formulated as a dynamic programming problem. Production equations derived from trial data are used to obtain an optimal sequence of rations in which energy density changes through time. The stability of the plan is explored and the implications of the results for production research and commercial practice are considered
OPTIMAL FEEDING POLICIES FOR BROILER PRODUCTION: AN APPLICATION OF DYNAMIC PROGRAMMING
The determination of an optimal feeding and selling strategy for broiler production given a space constraint is formulated as a dynamic programming problem. Production equations derived from trial data are used to obtain an optimal sequence of rations in which energy density changes through time. The stability of the plan is explored and the implications of the results for production research and commercial practice are considered.Livestock Production/Industries,
Outcomes and predictors of mortality after liver resection for hepatocellular carcinoma with macrovascular invasion: a cohort study
First-degree living-related donor liver transplantation in autoimmune liver diseases.
Liver transplantation (LT) is the treatment of choice for endâstage autoimmune liver diseases. However, the underlying disease may recur in the graft in some 20% of cases. The aim of this study is to determine whether LT using living donor grafts from firstâdegree relatives results in higher rates of recurrence than grafts from more distant/unrelated donors. Two hundred sixtyâthree patients, who underwent a first LT in the Toronto liver transplant program between January 2000 and March 2015 for autoimmune liver diseases, and had at least 6 months of postâLT followâup, were included in this study. Of these, 72 (27%) received a graft from a firstâdegree livingârelated donor, 56 (21%) from a distant/unrelated living donor, and 135 (51%) from a deceased donor for primary sclerosing cholangitis (PSC) (n = 138, 52%), primary biliary cholangitis (PBC) (n = 69, 26%), autoimmune hepatitis (AIH) (n = 44, 17%), and overlap syndromes (n = 12, 5%). Recurrence occurred in 52 (20%) patients. Recurrence rates for each autoimmune liver disease were not significantly different after firstâdegree livingârelated, livingâunrelated, or deceasedâdonor LT. Similarly, time to recurrence, recurrenceârelated graft failure, graft survival, and patient survival were not significantly different between groups. In conclusion, firstâdegree livingârelated donor LT for PSC, PBC, or AIH is not associated with an increased risk of disease recurrence